Stop CMV Act of 2024

The Stop CMV Act of 2024 requires hospitals and healthcare entities caring for infants under 21 days old to administer congenital Cytomegalovirus (CMV) screening tests. It mandates states to establish screening standards within two years of enactment, with federal oversight by the Advisory Committee on Heritable Disorders if states fail to act. The bill allocates federal grants to states for implementing screening, improving data systems, and funding research on CMV diagnostics, prevention, and treatments through the National Institutes of Health. These provisions directly affect newborns, hospitals, and state health agencies by standardizing early CMV detection and supporting related public health efforts.